Zobrazeno 1 - 10
of 355
pro vyhledávání: '"Mark, Kidd"'
Autor:
Jianing Yang, Mark Kidd, Alan R. Nordquist, Stanley D. Smith, Cedric Hurth, Irvin M. Modlin, Frederic Zenhausern
Publikováno v:
Infectious Disease Reports, Vol 13, Iss 4, Pp 1061-1077 (2021)
Since the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in December 2019, the spread of SARS-CoV2 infection has been escalating rapidly around the world. In order to provide more timely access to medical interv
Externí odkaz:
https://doaj.org/article/7a1a1fcd552c44cfae522ef3bcf92734
Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems
Autor:
Ashley K Clift, Omar Faiz, Robert Goldin, John Martin, Harpreet Wasan, Marc-Olaf Liedke, Erik Schloericke, Anna Malczewska, Guido Rindi, Mark Kidd, Irvin M Modlin, Andrea Frilling
Publikováno v:
Endocrine Connections, Vol 6, Iss 2, Pp 71-81 (2017)
Neuroendocrine tumours (NET) are clinically challenging due to their unpredictable behaviour. Nomograms, grading and staging systems are predictive tools with multiple roles in clinical practice, including patient prognostication. The NET nomogram al
Externí odkaz:
https://doaj.org/article/eeaf83cef38147209112bb0cf6369693
Autor:
Simon Schimmack, Ben Lawrence, Barton Kenney, Hubertus Schmitz-Winnenthal, Irvin M. Modlin, Mark Kidd
Publikováno v:
Translational Oncology, Vol 9, Iss 5, Pp 411-418 (2016)
BACKGROUND: Small intestinal neuroendocrine neoplasm (SI-NEN) proliferation is quantified by Ki67 measurements which capture G1-G2M phases of the cell cycle. G0 and early G1 phases, typical of slow-growing cells, can be detected by minichromosome mai
Externí odkaz:
https://doaj.org/article/47706cf0488b404794b77ac341d29891
Autor:
Mark Kidd, Ignat A Drozdov, Somer Matar, Nicole Gurunlian, Nicholas J Ferranti, Anna Malczewska, Philip Bennett, Lisa Bodei, Irvin M Modlin
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0218592 (2019)
BACKGROUND:Multigene-based PCR tests are time-consuming and limiting aspects of the protocol include increased risk of operator-based variation. In addition, such protocols are complex to transfer and reproduce between laboratories. AIMS:Evaluate the
Externí odkaz:
https://doaj.org/article/e26ca457818043c9a8830433ce6ce5b4
Autor:
Kjell Oberg, Eric Krenning, Anders Sundin, Lisa Bodei, Mark Kidd, Margot Tesselaar, Valentina Ambrosini, Richard P Baum, Matthew Kulke, Marianne Pavel, Jaroslaw Cwikla, Ignat Drozdov, Massimo Falconi, Nicola Fazio, Andrea Frilling, Robert Jensen, Klaus Koopmans, Tiny Korse, Dik Kwekkeboom, Helmut Maecke, Giovanni Paganelli, Ramon Salazar, Stefano Severi, Jonathan Strosberg, Vikas Prasad, Aldo Scarpa, Ashley Grossman, Annemeik Walenkamp, Mauro Cives, Irene Virgolini, Andreas Kjaer, Irvin M Modlin
Publikováno v:
Endocrine Connections, Vol 5, Iss 5, Pp 174-187 (2016)
The complexity of the clinical management of neuroendocrine neoplasia (NEN) is exacerbated by limitations in imaging modalities and a paucity of clinically useful biomarkers. Limitations in currently available imaging modalities reflect difficulties
Externí odkaz:
https://doaj.org/article/5d8a8bed100240668fb5e3ecc362659c
Publikováno v:
Endocrine-Related Cancer. 28:731-744
Pheochromocytomas and paragangliomas (PHEOs/PGLs) represent diagnostically challenging and complex neuroendocrine tumors (NETs). Current biomarker tests for PHEOs/PGLs are technically complex or limited. We assessed the diagnostic utility of a NET-sp
Publikováno v:
Current Opinion in Endocrine and Metabolic Research. 19:52-60
The recent development of peptide receptor radionuclide therapy (PRRT) into an accepted treatment allows for consideration of the requirements to move beyond the mere concept of tumor therapy. This chapter addresses the limitations of the “huff and
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 1, Iss 2, Pp 131-153 (2015)
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN), considered a heterogeneous neoplasia, exhibit ill-defined pathobiology and protean symptomatology and are ubiquitous in location. They are difficult to diagnose, challenging to manage, and ou
Externí odkaz:
https://doaj.org/article/b1ac85185c6243748c49049f06d5b7d7
Autor:
Massimo Falconi, Andrea Frilling, Irvin M. Modlin, Pier Luigi Filosso, Anna Malczewska, Mark Kidd, Alexandra Kitz
Publikováno v:
Annals of Surgery. 274:481-490
INTRODUCTION Identification of residual disease after neuroendocrine tumor (NET) resection is critical for management. Post-surgery imaging is insensitive, expensive, and current biomarkers ineffective. We evaluated whether the NETest, a multigene li
Autor:
Mark Kidd, Irvin M. Modlin
Publikováno v:
Current Opinion in Endocrine and Metabolic Research. 18:258-267
In respect of carcinoid disease, one might well ask, why have we failed so miserably? In 1907, Oberndorfer described “karzinoide” and yet more than a century later, most diagnoses still reflect incurable metastatic disease. Attempts to address th